Attached files
file | filename |
---|---|
8-K - CURRENT REPORT - MusclePharm Corp | mslp_8k.htm |
Exhibit 16.1
October
4, 2018
Securities and Exchange Commission
Washington, D.C. 20549
Commissioners:
We have read MusclePharm Corporation’s statements included
under Item 4.01 of its Form 8-K filed on October 4, 2018 and we
agree with such statements concerning our firm.
/s/EKS&H LLLP
EKS&H LLLP